Profile
Derek Maclean worked as a Director of Product Engineering at Amgen, Inc. and as a Director of Chemistry & Manufacturing at KAI Pharmaceuticals, Inc. He also worked as a Vice President of Chemistry Research at Relypsa, Inc. Currently, he is working as a Vice President of Pharmaceutical Sciences at Applied Molecular Transport, Inc. Dr. Maclean holds a doctorate degree from The University of Edinburgh.
Former positions of Derek Maclean
| Companies | Position | End |
|---|---|---|
| APPLIED MOLECULAR TRANSPORT INC. | Corporate Officer/Principal | 2023-12-26 |
KAI Pharmaceuticals, Inc.
 KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KAI Pharmaceuticals, Inc. discovers and develops biopharmaceutical drugs. It is a multiple, novel clinical-stage programs in the areas of cardiovascular, renal, and pain. The company was founded in 2002 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
| AMGEN INC. | Corporate Officer/Principal | - |
| RELYPSA INC | Corporate Officer/Principal | - |
Training of Derek Maclean
| The University of Edinburgh | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| APPLIED MOLECULAR TRANSPORT INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Private companies | 2 |
|---|---|
Relypsa, Inc.
 Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Relypsa, Inc. operates as a bio-pharmaceutical company, which engages in the development and commercialization of late-stage medicines in the iron deficiency, nephrology, and cardio-renal therapeutic areas. It offers Veltassa, a potassium binder approved for the treatment of hyperkalemia. The company was founded by Jerry M. Buysse, Gerrit Klaerner, Michael Burdick, Jay P. Shepard, Detlef F. Albrecht, George Tyson, Sandra I. Coufal and Vic Ciaravino on October 29, 2007 and is headquartered in Redwood City, CA. | Health Technology |
KAI Pharmaceuticals, Inc.
KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KAI Pharmaceuticals, Inc. discovers and develops biopharmaceutical drugs. It is a multiple, novel clinical-stage programs in the areas of cardiovascular, renal, and pain. The company was founded in 2002 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Derek Maclean
